阿托皮炎的表观遗传学:病原和治疗前景
1The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China; Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, Hunan, China; Furong Labratory, Changsha, Hunan, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, Hunan, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.
在DNA甲基化的表观遗传变化,非编码RNA和基因素修饰是理解亚托皮性皮炎 (AD) 的关键. 这些变化为这种慢性皮肤疾病提供了针对性治疗和个性化医疗方法的潜在生物标志物.
科学领域:
- 皮肤病学和免疫学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 亚托皮炎 (AD) 是一种慢性炎症性皮肤病,对身体和精神健康有重大影响.
- 关键的临床特征包括,化和干燥的皮肤,复杂和不完全理解的病因和发病因.
- 越来越多的证据将AD的发病与免疫细胞和角质细胞的表观遗传变化联系在一起.
研究的目的:
- 审查表观遗传修饰在阿托皮性皮肤炎发病过程中的作用.
- 要突出DNA甲基化,非编码RNA和基因组修饰对AD的影响.
- 强调表观遗传修饰作为新型治疗策略的生物标志物的潜力.
主要方法:
- 关于表观遗传学和亚托皮性皮肤炎的当前科学文献的综述.
- 分析DNA甲基化,非编码RNA和基因组修饰的作用.
- 综合有关免疫细胞和角质细胞表观遗传变化的发现.
主要成果:
- 表观遗传修饰,包括DNA甲基化,非编码RNA和基因素修饰,显著影响AD的发病.
- 这些表观遗传变化观察到涉及AD的关键细胞类型,如免疫细胞和角质细胞.
- 表观遗传改变为开发向生物标志物和个性化治疗提供了有希望的途径.
结论:
- 表观遗传学研究提供了对亚托邦性皮肤炎病变的关键见解.
- 表观遗传修饰作为AD的潜在向生物标志物.
- 这些生物标志物可以促进开发新的向疗法和个性化医学方法来治疗AD.
相关概念视频
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Clinical Applications of Epidermal Stem Cells
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Renewal of Skin Epidermal Stem Cells
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:


